Global Pirfenidone Market Growth 2023-2029

Global Pirfenidone Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Pirfenidone Industry Forecast” looks at past sales and reviews total world Pirfenidone sales in 2022, providing a comprehensive analysis by region and market sector of projected Pirfenidone sales for 2023 through 2029. With Pirfenidone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone industry.

This Insight Report provides a comprehensive analysis of the global Pirfenidone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pirfenidone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone.

The global Pirfenidone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pirfenidone players cover Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals and Koye Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Tablet
Capsule
Other

Segmentation by application
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pirfenidone market?

What factors are driving Pirfenidone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pirfenidone market opportunities vary by end market size?

How does Pirfenidone break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.